Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.
Also called NCT01849497
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 149 participants
- Sponsor
- Registry
-
NCT01849497
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- Not reported
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01849497. Randomized; no masking; primary purpose treatment. Start 2013-04-18 (actual); primary completion 2013-09-02 (actual). Results posted on 2015-10-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen
- Condition
- Primary Hypercholesterolemia
- Condition
- Mixed Dyslipidemia
- Intervention (Biological)
- Evolocumab Pre-filled Syringe
- Intervention (Biological)
- Evolocumab AI/pen
- Lead sponsor
- Amgen
Record details
- Record id
cardio:ct-nct01849497- Content hash
9fb086458bfa3ea5fc762f11ff1965edd4ba3481285b82490109dd272bf43431